To validate the RHPN2 expression in LUAD and other cancer types, we obtained the RNA sequencing data and corresponding clinical information from TCGA and found that RHPN2 mRNA levels were higher in tumor tissues than normal tissues in LUAD, LUSC and other cancer types (Figures 1A, B). The gene discussed is RHPN2; the disease is neoplasm.